Patrick S. Stayton, Ph.D.
Washington Research Foundation Endowed Professor in Bioengineering
Professor, Department of Bioengineering
Dr. Stayton is the director of the Institute for Molecular Engineering and Sciences and the Center for Intracellular Delivery of Biologics. He received his B.S. in biology (summa cum laude) from Illinois State University, his Ph.D. in biochemistry from the University of Illinois, and he was a postdoctoral research associate at the Beckman Institute for Advanced Science and Technology, also at the University of Illinois.
Dr. Stayton’s eclectic research group works at the interface of fundamental molecular science and applied molecular bioengineering. His laboratory has pioneered new drug delivery systems for biologic drugs and vaccines and new nanotechnologies for diagnostic and regenerative technologies. Dr. Stayton has a strong interest in translating the group’s research, has been awarded several patents, and is a co-founder of two start-up companies: PhaseRx Inc., based on his group’s drug delivery work, and Nexgenia, based on their diagnostic work.
Dr. Stayton has been elected as a fellow of the American Institute for Medical and Biological Engineering and has received the Clemson Award from the Society for Biomaterials and the CRS-Cygnus Recognition Award from the Controlled Release Society. He served as co-chair of the Gordon Conference on Drug Carriers in Medicine and Biology in 2010. He has also been awarded the 2009 Faculty Research Innovation Award in the UW College of Engineering, a Distinguished Teacher and Mentor Award from the Department of Bioengineering, and an honorary award from the College of Engineering’s Minority Science and Engineering Program.
Learn more about:
If you’re interested in this field, please consider making a gift to this fund through the UW Foundation.